Market Signal Briefing

New York, New York--(Newsfile Corp. - December 16, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws.

If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.

Investors have until January 12, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Stride securities. The case is pending in the U.S. District Court for the Eastern District of Virginia and is captioned MacMahon v. Stride, Inc., et al., No. 1:25-cv- 02019.

Why is Stride Being Sued for Securities Fraud?

Stride is an education technology company that provides an online platform to students throughout the U.S. During the relevant period, Stride stated it was seeing "increasing growth in our business," "in-year strength in demand" for its products and services, and that its customers and potential customers "continue to choose us in record numbers."

As alleged, in truth, Stride had inflated enrollment numbers by retaining "ghost students," ignored compliance requirements for its employees, and had "poor customer experience" that resulted in "higher withdrawal rates," "lower conversion rates," and had driven students away.

Why did Stride's Stock Drop?

On September 14, 2025, a report stated that a complaint had been filed against Stride for fraud, deceptive trade practices, systemic violations of law, and intentional and tortious misconduct. It claimed Stride inflated enrollment numbers by retaining "ghost students" on rolls to secure state funding and ignored compliance requirements, including background checks and licensure laws for its employees. This news caused the price of Stride stock to drop $18.60 per share, or more than 11%, from a closing price of $158.36 per share on September 12, 2025, to $139.76 per share on September 15, 2025.

Then, on October 28, 2025, Stride admitted that "poor customer experience" resulted in "higher withdrawal rates," "lower conversion rates," and drove students away. Stride estimated the impact caused approximately 10,000-15,000 fewer enrollments and stated that, because of this, its outlook is "muted" compared to prior years. This news caused the price of Stride stock to drop $83.48 per share, or more than 54%, from a closing price of $153.53 per share on October 28, 2025, to $70.05 per share on October 29, 2025.

Click here for more information: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.

What Can You Do?

If you invested in Stride you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277906

Source: Bleichmar Fonti & Auld

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

New York, New York--(Newsfile Corp. - December 16, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.

If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.

Investors have until January 5, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Inspire stock. The case is pending in the U.S. District Court for the District of Minnesota and is captioned City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., et al., No. 0:25-cv-04247.

Why is Inspire Being Sued for Securities Fraud?

Inspire develops and manufactures an implantable medical device for the treatment of sleep apnea. The latest version of the device is the Inspire V. The company announced FDA approval of Inspire V on August 2, 2024.

During the relevant period, Inspire repeatedly assured investors that it had taken all necessary steps to facilitate the launch of Inspire V and that it would launch the device as soon as sufficient inventory was available to meet supposedly high demand.

As alleged, in truth, Inspire failed to take basic steps to prepare clinicians and payors for the rollout, resulting in significant delays in adoption of the device. Moreover, the launch suffered from weak demand, as many customers already had excess inventory of the company's older devices.

Why did Inspire's Stock Drop?

On August 4, 2025, Inspire disclosed that the Inspire V launch was facing an "elongated timeframe" and as a result, it was reducing its 2025 earnings per share guidance by more than 80%. The company attributed the longer timeframe to a number of previously undisclosed factors including that many implanting centers "did not complete the training, contracting and onboarding required prior to the purchase and implant of Inspire V," that certain "software updates for claims submissions and processing did not take effect until July 1, [2025]" which meant implanting centers could not bill for procedures until that date, and that demand for the Inspire V was poor because Inspire's customers had a backlog of older versions of the company's device.

On this news, the price of Inspire stock dropped $42.04 per share, or more than 32%, from $129.95 per share on August 4, 2025, to $87.91 per share on August 5, 2025.

Click here for more information: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.

What Can You Do?

If you invested in Inspire you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277902

Source: Bleichmar Fonti & Auld

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

HomeDividends AnalysisDividend IdeasFinancials 

SummarySixth Street Specialty Lending, Inc. remains a Hold due to valuation and interest rate headwinds, despite strong portfolio quality.TSLX's high share of floating-rate debt (96.3%) now pressures yields as rates decline, with net investment income down 8.5% year-over-year.Regular dividend coverage is solid at ~117%, but future cuts may erode this margin of safety. Still, the total dividend is already lower than it used to be.TSLX trades at a 27.5% premium to NAV, limiting upside and making multiple expansion unlikely in the current environment. PM Images/DigitalVision via Getty Images

I've covered Sixth Street Specialty Lending, Inc. (TSLX) 5 times before, with a Hold as my last rating. I expected stock price declines due to the unfavorable interest rate changes and

Analyst’s Disclosure:I/we have a beneficial long position in the shares of TSLX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The information, opinions, and thoughts included in this article do not constitute an investment recommendation or any form of investment advice.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

December 16, 2025 13:59 ET

 | Source:

Gray Media

ATLANTA, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Bahakel Communications, Limited has reached an agreement to sell its Jackson, Tennessee, ABC affiliate WBBJ-TV, known locally as WBBJ 7, to Gray Media, Inc.

Since its launch 70 years ago, WBBJ 7 has been the most-watched local news television station in its market. Upon closing, the station will join Gray’s portfolio of leading local news television stations across the country and throughout the region, including in the adjacent markets of Nashville, Memphis, Huntsville and Paducah.

“Gray is honored to be entrusted by Bahakel Communications as the next long-term stewards of WBBJ 7,” said Kevin Latek, Gray’s Chief Legal and Development Officer. “We look forward to welcoming the station and its dedicated employees into our extensive local news and sports operations in this region and working with these employees to further enhance their long record of service to local viewers and businesses.”

“This sale marks a pivotal step for Bahakel Communications as we focus our footprint and strengthen our digital platforms and entertainment division,” said Beverly Bahakel, CEO. “We are committed to ensuring a smooth and positive transition for WBBJ’s audience, advertisers, and employees. We believe Gray is the right group to build on WBBJ’s longstanding legacy of serving the Jackson community and its commitment to delivering trusted local news and information.” 

This transaction advances Gray’s strategy of enhancing shareholder value through select acquisitions of highly rated stations that share the culture and values of our existing television stations. Gray anticipates that the transaction will be immediately free cash flow accretive, and it expects to fund the acquisition with cash on hand. The parties anticipate closing the transaction following receipt of regulatory and other approvals in the first quarter of 2026.

Kalil & Co., Inc. represented Bahakel in this transaction.

About Bahakel Communications:

Bahakel Communications, founded by Cy N. Bahakel in 1947 and based in Charlotte, North Carolina, is a family-owned media company that operates television and radio stations. The company has a long history of media innovation and is known for its local broadcasting. Bahakel also runs a full-service digital marketing agency, Bahakel Digital, in addition to entertainment programming, sports production, and streaming through Bahakel Sports & Entertainment.

About Gray Media:

        Gray Media, Inc. (NYSE: GTN) is a multimedia company headquartered in Atlanta, Georgia. The company is the nation’s largest owner of top-rated local television stations and digital assets serving 113 television markets that collectively reach approximately 37 percent of US television households. The portfolio includes 78 markets with the top-rated television station and 99 markets with the first and/or second highest rated television station during 2024, as well as the largest Telemundo Affiliate group with 44 markets. The company also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with the most advanced digital products and services. Gray’s additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. For more information, please visit

www.graymedia.com.

Forward-Looking Statements:

This press release contains certain forward-looking statements that are based largely on Gray’s current expectations and reflect various estimates and assumptions by Gray. These statements are statements other than those of historical fact and may be identified by words such as “estimates,” “expect,” “anticipate,” “will,” “implied,” “assume” and similar expressions. Forward-looking statements are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such forward-looking statements. Such risks, trends and uncertainties, which in some instances are beyond Gray’s control, include the inability to complete, or realize the expected benefits of, the proposed acquisition, within the expected timeframe, or at all, and other future events. Gray is subject to additional risks and uncertainties described in its quarterly and annual reports filed with the Securities and Exchange Commission from time to time, including in the “Risk Factors,” and management’s discussion and analysis of financial condition and results of operations sections contained therein, which reports are made publicly available via www.sec.gov. Any forward-looking statements in this communication should be evaluated in light of these important risk factors. This press release reflects management’s views as of the date hereof. Except to the extent required by applicable law, Gray undertakes no obligation to update or revise any information contained in this communication beyond the date hereof, whether as a result of new information, future events or otherwise.

Contact:

Kevin P. Latek, Executive Vice President, Chief Legal and Development Officer, 404-266-8333

# # #

December 16, 2025 14:00 ET

 | Source:

Heartland Express, Inc.

NORTH LIBERTY, Iowa, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Heartland Express, Inc. (Nasdaq: HTLD) announced today the declaration of a regular quarterly cash dividend. The $0.02 per share dividend will be paid on January 7, 2026, to shareholders of record at the close of business on December 26, 2025. We currently estimate that a total of $1.6 million will be paid on the Company's approximate seventy-eight million shares of common stock. This is the Company's ninetieth consecutive quarterly cash dividend. With the payment of this dividend, the Company will have paid a total of $561.4 million in cash dividends, including four special dividends since the dividend program was implemented in the third quarter of 2003.

The press release may contain forward-looking statements, which are based on information currently available. These statements and assumptions involve certain risks and uncertainties. Actual events may differ from these expectations as specified from time to time in filings with the Securities and Exchange Commission. The Company assumes no obligation to update any forward-looking statement to the extent it becomes aware that it will not be achieved for any reason.

For further information contact
Michael J. Gerdin, CEO
Christopher A. Strain, CFO
Heartland Express, Inc.
319-645-7060

, /PRNewswire/ -- Unisys (NYSE: UIS) has received the Enterprise & AI Innovation Award from Silicon Valley-based innovation platform Plug and Play. This recognition underscores the company's commitment to collaboration and leadership, reinforcing its role as a catalyst for transformative AI solutions. Plug and Play's global network connects over 100,000 startups, partners and investors to drive innovation and economic growth.

Plug and Play noted that Unisys stood out for its agile yet systematic approach to innovation, as well as its ongoing engagement with startups and industry peers to unlock new growth opportunities. Unisys actively participates in the Plug and Play ecosystem by conducting regular deal flows and pilots with startups and partners throughout the year, fostering a dynamic exchange of ideas and technologies.

"Plug and Play's recognition of our enterprise and AI innovation is a testament to what we can achieve when we embrace collaboration and stay relentlessly curious," said Chris Bennett, vice president of the AI & Machine Learning Practice at Unisys. "Unisys' passion for new technologies fuels our growth and paves new avenues for our clients and partners. Together, we're shaping the future with AI not as spectators, but as active creators of impact."

This is the second time Unisys has received the Enterprise & AI Innovation Award from Plug and Play, having previously received the honor in 2023. Plug and Play also recognized Unisys for continuing to evolve after more than 150 years in business, delivering market-leading solutions to clients.

To learn more about the AI offerings from Unisys, click here.

About Unisys
Unisys is a global technology solutions company that powers breakthroughs for the world's leading organizations. Our solutions – cloud, AI, digital workplace, applications and enterprise computing – help our clients challenge the status quo and unlock their full potential. To learn how we have been helping clients push what's possible for more than 150 years, visit unisys.com and follow us on LinkedIn.

RELEASE NO.: 1216/10027
Unisys and other Unisys products and services mentioned herein, as well as their respective logos, are trademarks or registered trademarks of Unisys Corporation. Any other brand or product referenced herein is acknowledged to be a trademark or registered trademark of its respective holder.
UIS-C

SOURCE Unisys Corporation

SAN FRANCISCO--(BUSINESS WIRE)--Square today announced that it has expanded its partnership with Thrive, the leading inventory management reporting system, to give sellers a seamless way to manage their catalogs, sales, and stock between their in-store and e-commerce platforms, including Shopify. The new integration enables retailers to create and edit products within Square, and have those updates automatically reflected on Shopify. With Square serving as the source of truth, sellers can avoid.

The cruising giant reports quarterly results this week. It didn't go very well last time.

The past few weeks have been a bon voyage for investors in cruise line stocks. Carnival Corp. (CCL 0.87%) -- the country's largest player by revenue -- has seen its shares coast 10% higher over the past month. This would be cause for a party on the pool deck, but comparison is the thief of joy sometimes.

Rival Royal Caribbean -- the country's largest player by market cap -- is up a more robust 13% in the same time. Even historical laggard Norwegian Cruise Line is up a hefty 18% over the past month. The three largest cruise line stocks are moving higher after taking on water in the previous months, but does Carnival have a shot of leading the rally heading into next year instead of merely tagging along?

Carnival stock investors won't have to wait long to get a crack at taking control of the bullish turn. It reports its fiscal fourth-quarter results on Friday morning. Following a disappointing third-quarter update that triggered a sell-off, a shot at a redemption story fits the narrative of the holiday season. Let's see if Carnival can stick the landing.

Image source: Getty Images.

Riding the wave
Analysts have healthy growth expectations as Carnival steps up this week with fresh financials. The $6.38 billion that Wall Street pros are modeling for the fiscal quarter that ended in November would be a 7% increase. This is a step up from the mere 3% year-over-year increase it posted three months earlier. This would stretch Carnival's streak of record results for a particular quarter to 11 periods.

The growth should be even better on the bottom line. Analysts are targeting a profit of $0.25 a share, landing nearly 80% above the $0.14 a share it posted a year earlier. If that sounds ambitious, remember history favors the aggressive. Carnival has consistently topped the market's quarterly income expectations for more than two years.

PeriodEPS EstimateActual EPSSurpriseFiscal Q3 2023$0.75$0.8615%Fiscal Q4 2023($0.13)($0.07)46%Fiscal Q1 2024($0.18)($0.14)22%Fiscal Q2 2024($0.02)$0.11650%Fiscal Q3 2024$1.15$1.2710%Fiscal Q4 2024$0.07$0.1494%Fiscal Q1 2025$0.02$0.13485%Fiscal Q2 2025$0.35$0.2446%Fiscal Q3 2025$1.32$1.439%
Data source: Yahoo! Finance. EPS = earnings per share (adjusted).

Navigating the uncertain waters
Carnival's 3% revenue increase the last time out was potentially problematic, and not just because it's not ideal for a growth stock to merely keep pace with inflation. The modest 5% top-line growth that rivals Royal Caribbean and Norwegian would post a month later didn't help. This was also the seasonally potent summer quarter, making a slowdown look even worse.

Royal Caribbean and Norwegian are also expected to show improving revenue growth in their next quarterly updates. The market is banking on gains of 14% and 11%, respectively. Take a step back, joy thief. This is only to illustrate that growth is expected to accelerate again -- even if it finds Carnival in the back of the pack again.

In defense of Carnival's third-quarter showing three months ago, it did exceed expectations. It once again raised expectations across all of the metrics it publicly forecasts. The same company that initially braced investors for a fiscal 2025 profit of $1.70 per share has seen that per-share guidance rise to $1.83, $1.97, and now $2.14 with every passing report.

Even if it simply lands on its guidance, which it has gracefully overshot every quarter since returning to full operations after the prolonged COVID-19 shutdown, Carnival would be trading for just 13 times trailing earnings by the end of this week. That may seem cheap, but Norwegian is far cheaper.

Beating expectations wasn't enough last time. It might not be enough this time around. Carnival will have to show strong bookings ahead of the 2026 season. Its net yield -- a popular industry metric that measures adjusted gross margin per available passenger cruise day -- will need to exceed its already record results.

Could this be the moment that Carnival follows Royal Caribbean in reinstating its quarterly dividend? It can do a lot worse than following in the sandy footsteps of the market darling that commands a premium valuation over Carnival for some pretty good reasons. If Carnival wants to keep the recent upticks coming, it's going to have to show the market something it hasn't seen before.

Operator

[Audio Gap] Vice President of Investor Relations at Alliance Advisors IR, and I'm extremely pleased to moderate this webinar on behalf of Streamex Corp., NASDAQ ticker STEX. Joining us today is Henry McPhie, CEO and Co-Founder of Streamex.

Henry is a mining engineer and previous founder of companies in the crypto and blockchain space, including Lynx Web 3 Solutions, a blockchain incubation and software development firm and FCC, a Solana-based digital art project that quickly rose to become the third largest in the world at the time of its launch. Henry also co-founded Streamex alongside Co-Founder, Morgan Lekstrom.

Today, in addition, we have Mitch Williams, CIO of StreameX. Mitch was a former fintech analyst at Credit Suisse and sole Portfolio Manager at OppenheimerFunds Flagship Value Fund. Prior to that, Mitch was a Senior Managing Director and Global Head of Public Markets at Wafra Inc. Henry and Mitch will discuss recent company milestones and key growth highlights and provide some color on what's ahead for 2026.

Throughout the presentation, you are welcome to submit your questions via the question-and-answer function on your screen. We'll address as many as we can after the presentation concludes. And here's some housekeeping items.

Before we begin, I'd like to remind everyone that certain statements made during today's presentation may contain forward-looking information as defined under applicable securities laws. These statements could include estimates, projections, goals, forecasts or assumptions based on current expectations and are not reflective of historical facts. It's important to note that such forward-looking statements represent the company's beliefs regarding future events, plans or objectives. These are inherently uncertain and subject to various risks and uncertainties that could cause actual results or performance to

On this episode of the “ETF of the Week” podcast, VettaFi’s Head of Research, Todd Rosenbluth, discussed the VictoryShares Free Cash Flow Growth ETF (GFLW) with Chuck Jaffe of Money Life. The pair discussed several topics related to the fund to give investors a deeper understanding of the ETF.

Chuck Jaffe: One fund, on point for today. The expert to talk about it. Welcome to the ETF of the Week!

Yes, this is the ETF of the Week, where we examine trending, new, newsworthy, unique, and intriguing exchange-traded funds with the help of Todd Rosenbluth. He’s the head of research at VettaFi, and at VettaFi.com, their website has all the tools you need to make yourself a better, smarter, savvier investor in ETFs.

Todd Rosenbluth, great to chat with you again.

Your ETF of the Week is…

Todd Rosenbluth: The VictoryShares Free Cash Flow Growth ETF. GFLW.

Chuck Jaffe: GFLW, VictoryShares Free Cash Flow Growth ETF! So, a couple of things that we don’t always see in names. Like… Yes, you have growth there, but free cash flow. That’s a distinctive style. So explain what it is that you’re looking for, and why this fund now.

Todd Rosenbluth: So, this is a quality growth ETF. I tend to think of free cash flow as a wonderful metric to assess high quality in a company. Because if you’ve got strong free cash flow and it’s growing, that’s a positive sign. This ETF from VictoryShares came to market at the end of 2024. And it’s one of those funds that’s doing quite well. Doing quite well in that it’s gathering assets this year. Doing quite well that it’s actually outperforming the traditional growth benchmark, the Russell 1000 Growth this year, in an environment where high growth is a priority. 

I think we’re going to see a bit more volatility in 2026. I think we all expected we were going to have more of it, but I think we’re going to see more of it actually occur in 2026. And so for people who are looking for a growth strategy, this is a factor-focused, smarter way of investing in growth, in my opinion. 

Chuck Jaffe: It’s a fund that has done very well this year. It’s up more than 20%, which is a couple of percentage points ahead of the category. What is it doing to generate that kind of performance that puts it in the top quartile of its peer group?

Todd Rosenbluth: So, this takes a look at growth companies and assesses them based on their free cash flow generation. Both a forward-looking and a backward-looking approach. That’s, I think, different than some of the other quality metrics, quality-based ETFs that are out there that only look backward. This takes a forward-looking approach. 

Now with a growth ETF, you’d expect to find technology stocks. And you will find them in here. But I notice when we’re looking relative to the Russell 1000 Growth that this is slightly underweight towards technology stocks. But it’s overweighted towards healthcare and industrial companies, as we’re talking in mid-December.

Now, this is an ETF that rebalances periodically. In fact, VettaFi is an index partner with VictoryShares in support of this. But what caught my eye is this fund has gathered over $500 million of assets this year. It’s now up to $650 million. That’s particularly compelling. I know you and I have talked a lot about active ETFs this year and the growth of active ETFs. This to me is a good example of — there’s still demand for an index-based strategy.

Chuck Jaffe: And at the same time, it is an index-based strategy that does include a couple of the biggest names, which is not a big surprise. You can’t really have a large growth fund and not have Nvidia and Alphabet and a couple of other names like that in the portfolio. So, large growth is the category where almost everybody… Of, you know, whatever your first mutual fund is, et cetera., large growth is… There’s a good chance that’s where people have stuff.

So, if people are going to look at this fund, we know they have the category. They may not have the allocation mix. If you’ve already got one growth fund, is it the style that gives you the diversification here, and it’s worth adding a little bit of portfolio complexity to do it? Or is there something else that’s going to drive that investment decision?

Todd Rosenbluth: So we’ve seen, I believe what we’ve seen, is that investors are using this as a complement to their growth strategy, either to reduce their concentration risk, or, and/or, just because this might be a better way of doing it. Let me stay on that concentration risk. 

You’re right. Nvidia and Alphabet are the two largest holdings in the most recent look at it. But they’re roughly 4% each of the portfolio. And that’s intentional, because the index has a capping component to it. And so as I look through the top ten holdings or recent top ten holdings, I see Booking Holdings, I see DoorDash, I see Spotify Technology, Palantir. 

These are all companies, growth companies people have heard of. But you won’t find the same exposure — you know, 2% to 4% exposure to these companies — in a Russell 1000 or even the Nasdaq 100 market cap-weighted approach, which is dominated by those Mag Seven stocks.

So, I think people are using this VictoryShares ETF, GFLW, to diversify away from the mega-cap companies — have some exposure, but not have all of their eggs in that basket, because those stocks won’t go up forever.

Chuck Jaffe: Expense ratio on this is 39 basis points, 0.39%. And I’m curious there, because we’ve talked a lot about expense ratios. And I know that it’s not a big determining factor as long as it doesn’t get, you know, too high or what have you. But I’m old enough to remember when 39 basis points would have been a big bargain on an actively managed large-cap growth fund.

Of course, the ETF revolution changed that and has made it that, you know, 39 basis points… Not bad. Not the best for you. And this is not a question I’ve ever really asked you. Is there a level where you go, “Hey, this is really expensive for an ETF in a big category like this”? And below? 

Like, is there a level where you look and say, “For what I’m getting on an actively managed ETF that’s buying domestic stocks and not doing something that’s particularly tricky, I want to see an expense ratio below this, because anything above it strikes me as costly”?

Todd Rosenbluth: So, I think if you’re investing in a market cap-weighted approach, which is just simple and I guess a crude way of doing it, there’s nothing wrong with it. That’s just a simple way of doing it.

You’re going to find strategies that are 10 basis points or less. I think that actually the Russell 1000 growth ETFs might be a little bit higher, certainly the iShares one that is the largest of those products. 

With active, or even in this case, index-based but factor — where it rebalanced a couple of times throughout the year as a result of a look at quality growth metrics — I think 39 basis points is reasonable. But to me, an expense ratio is one of those things on your checklist when you’re comparing ETFs.

And so if you look at the performance of this fund in the albeit short one-year time period, it has outperformed, I believe, the iShares Russell 1000 Growth ETF, despite being slightly more expensive. So, if that… That’s certainly a positive thing. And then you’d want to look at some of the other characteristics, as we talked about. 

It’s not as concentrated; you get exposure to not just technology stocks within a growth ETF. Those are all those things I would want to consider when I’m looking at an ETF, and I would hope that investors and advisors would do that also. Not just looking at the cheapest ETF, but finding the best ETF for them.  

Chuck Jaffe: Sometimes when we’re looking at a fund, you’re looking at it as something you add to the portfolio as a long-term holding. Sometimes it’s tactical. This seems, maybe smells to me, like this is long-term. You’d want to do this for that diversification of your large-cap sort of side of things. If you need some of that. But is this tactical, or is this that long-term hold?

Todd Rosenbluth: So, I think this is a strategic position to be able to have as a complement to your existing large-cap growth or large-cap oriented ETF that is tilted towards growth, because it’s concentrated. I don’t know if I have strong enough views, but heading into the year, many people are optimistic and are leaning towards some of those growth companies to continue to head higher, with consciousness from a valuation standpoint.

So this could be a tactical move as you start the year. And we see if the moderately bullish mindset continues.

And if that isn’t the case, then you might want to dial this back. There are other ETFs that offer a quality approach but are not as growth-oriented. In fact, I’d be remiss — we talked about one of those from Victory, VFLO. VFLO is the more value-oriented brother/sister/cousin of GFLW. You could be able to rotate between those two ETFs depending upon growth versus value.

Chuck Jaffe: And that would be an interesting way to play it. But this is an interesting pick as a potential add to a portfolio. It’s GFLW. GFLW, the VictoryShares Free Cash Flow Growth ETF, the ETF of the Week from Todd Rosenbluth at VettaFi. Todd, great stuff. See you again next week!

Todd Rosenbluth: Thanks a lot, Chuck. You too.

Chuck Jaffe: The ETF of the Week is a joint production of VettaFi and Money Life with Chuck Jaffe. And I’m Chuck Jaffe, and I’d love it if you check out my hour-long weekday podcast at MoneyLifeShow.com or by searching for it wherever you find your favorite podcast. 

Now, if you’re searching for information on your favorite ETFs, or maybe something we talked about here that could be your next favorite ETF, no better place to go looking for information than VettaFi.com, where they’ve got a full suite of details and information that’ll help you out. They’re on X at @Vetta_Fi. Todd Rosenbluth, their head of research, my guest, he’s on X too at @ToddRosenbluth. 

The ETF of the Week is here for you every Thursday. Make sure you don’t miss an episode by following along on your favorite podcast app, and we’ll be back with another ETF for you to consider again next week. But until then, happy investing everybody!

Note: This article was created in part through assistance from AI tools. The content has been thoroughly reviewed and edited by the author. 

For more news, information, and strategy, visit the Free Cash Flow Content Hub.

Earn free CE credits and discover new strategies

CNBC's "The Exchange" team discusses what may be next for markets and the U.S. economy in 2026 with Liz Ann Sonders, chief investment strategist at Charles Schwab.

Transition to take place December 17

December 16, 2025 14:20 ET

 | Source:

Freddie Mac

MCLEAN, Va., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today announced that its Board of Directors has selected Kenny M. Smith, a seasoned financial services leader, as the company’s chief executive officer (CEO), effective December 17. He also will serve as a member of the company’s Board of Directors. Michael Hutchins, who has served as interim CEO, will continue in his role as president.

Mr. Smith brings nearly 40 years of experience providing strategy, operational, risk management and governance counsel to a diverse array of financial services companies and institutions. He spent 27 years at Deloitte Consulting LLP in numerous positions, including five years as Vice Chairman, U.S. Financial Services Industry Leader. At Deloitte, he also served as Global Lead Client Service Partner for Wells Fargo & Company from 2008 to 2019, advising management on a wide variety of company matters.

“Kenny Smith's background and decades of experience in financial services will be an asset to Freddie Mac as we continue to meet the needs of homeowners, renters and the industry in 2026 and beyond.” said Mike Hutchins, president and interim CEO of Freddie Mac.

As Financial Services Industry Leader, Smith oversaw Deloitte’s financial services sectors, including banking and capital markets, real estate, insurance, and investment management. He also served as senior industry advisory partner for numerous clients.

"I am honored and excited to join the team at Freddie Mac," said Smith. "Freddie Mac plays a vital role in the nation's housing finance system, and I look forward to working with our talented team to expand access to homeownership and rental housing across the country."

Mr. Smith earned a Bachelor of Business Administration from Texas Tech University and was recognized as a Distinguished Alumni of the Rawls College of Business, where he also serves as an Emeritus Advisory Council member. He is a Certified Public Accountant.

MEDIA CONTACT: Christopher Spina
703-388-7031
[email protected]

HomeStock IdeasQuick Picks & Lists

Comments

SummaryThe Goldman Sachs International Equity ESG Fund Institutional Share Class underperformed its benchmark, the MSCI EAFE Index, by -384 basis points (BPS) in Q3 2025, on a net of fees basis.At the region level, stock selection in Asia/Pacific ex Japan was the greatest contributor to relative returns.At the sector level, Health Care and Real Estate were the only contributors to relative returns during the quarter.Single stock ideas excerpted from fund letters published by Seeking Alpha.

HomeStock IdeasQuick Picks & Lists

SummaryGoldman Sachs International Equity ESG Fund initiated a position in ING Group (2.6%), a Dutch global financial institution.We initiated a position in Air Liquide (2.0%), which produces, markets, and sells industrial and healthcare gases.We exited our position in Nestle, a large Swiss food and beverage company.We exited our position in DSM – Firmenich, a Dutch company that reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for customers worldwide.

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.

GLP-1 pills for obesity are closer than ever. 

2026 is likely the year that two new oral weight loss drugs will reach patients in the U.S. For some people, pills may serve as a more convenient – and potentially in certain cases cheaper – alternative to today's blockbuster injections.

Drugmakers Novo Nordisk and Eli Lilly have said their daily pills could help the drugs reach new patients. That could include people who are afraid of needles or patients who might benefit from the existing injections but don't take them because they don't view their need as severe enough. 

The upcoming pills aren't expected to be more effective than weekly injections, but health experts stress that expanding the range of treatment options could still be a major win for patients. After the injections hit nationwide supply shortages in recent years, Novo Nordisk and Eli Lilly have already started preparing enough of their pills to meet expected demand. 

In a note in August, Goldman Sachs analysts forecasted that pills will capture 24% share — or around $22 billion — of the 2030 global weight loss drug market, which they expect to be worth $95 billion in total.

Here's what to know about the upcoming pills.  

TimingMost importantly, Novo Nordisk could beat its rival to the market. The Danish drugmaker's oral semaglutide, the active ingredient in its obesity injection Wegovy and diabetes shot Mounjaro, is slated to win approval by the end of the year. 

That sets up the drug, which will be marketed as Wegovy in a pill, to launch early next year. 

Meanwhile, Eli Lilly has not yet filed for approval of its oral GLP-1, orforglipron, but the company is preparing to do so by the end of the year. The Food and Drug Administration in November said it has awarded a priority review voucher to that pill, which could expedite the review timeline for the drug to a few months. 

It's unclear exactly when that approval could be, but it's safe to say that the pill will enter the market sometime in 2026. 

CostNeither drugmaker has released specific list prices for their pills. But we already know that they're planning discounts for patients. 

Under recent deals with President Donald Trump, the companies said starting doses of their upcoming pills, pending approvals, will be $149 per month for everyone getting them through the direct-to-consumer website TrumpRx. That site launches in January. 

That's already cheaper than the planned discounted prices for Novo Nordisk and Eli Lilly's existing injections. Currently, drugs like Wegovy and Eli Lilly's obesity injection Zepbound carry list prices of roughly $1,000 per month before insurance. 

Efficacy and competitionIt's difficult to directly compare the results of separate clinical trials on the two drugs to compare their efficacy. What's more, Eli Lilly's ATTAIN-1 trial on its pill followed 3,000 patients with obesity or who were overweight, while Novo Nordisk's OASIS 4 study on its own oral drug evaluated a much smaller group of roughly 300. There are currently no studies directly comparing the two treatments. 

But Novo Nordisk's oral semaglutide appears to cause a greater level of weight loss than Eli Lilly's pill, based on the available data, some analysts have said. 

In Eli Lilly's trial, the highest dose of its pill helped patients lose 12.4% of their body weight on average at 72 weeks. The pill's weight loss was 11.2% when analyzing all patients regardless of discontinuations.

Meanwhile, the 25-milligram dose of Novo Nordisk's oral semaglutide helped patients lose up to 16.6% of their weight on average at 64 weeks, according to results from the trial presented at a medical conference in 2024. That weight loss was 13.6% when the company analyzed all patients regardless of whether they stopped the drug. 

Still, the slightly lower efficacy of Eli Lilly's pill may not be significant enough to deter patients from taking it.

In the August note, Goldman analysts said they expect Eli Lilly's pill to have a 60% share – or roughly $13.6 billion – of the daily oral segment of the market in 2030. They expect Novo Nordisk's oral semaglutide to have a 21% share – or around $4 billion – of that segment. It expects the remaining 19% slice to go to other emerging pills, the analysts said.

So, who's next? Viking Therapeutics, Structure Therapeutics, AstraZeneca, Roche and Pfizer are developing their own obesity pills, and we'll certainly see more data from those experimental drugs next year. 

Stay tuned for our coverage.

Feel free to send any tips, suggestions, story ideas and data to Annika at a new email: [email protected].

Analyst’s Disclosure:I/we have a beneficial long position in the shares of BANX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Investors might want to bet on La-Z-Boy (LZB - Free Report) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.

Analysts' growing optimism on the earnings prospects of this furniture company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For La-Z-Boy, there has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate RevisionsFor the current quarter, the company is expected to earn $0.59 per share, which is a change of -13.2% from the year-ago reported number.

The Zacks Consensus Estimate for La-Z-Boy has increased 5.36% over the last 30 days, as one estimate has gone higher compared to no negative revisions.

Current-Year Estimate RevisionsThe company is expected to earn $2.65 per share for the full year, which represents a change of -9.3% from the prior-year number.

In terms of estimate revisions, the trend for the current year also appears quite encouraging for La-Z-Boy. Over the past month, one estimate has moved higher compared to no negative revisions, helping the consensus estimate increase 7.72%.

Favorable Zacks RankThanks to promising estimate revisions, La-Z-Boy currently carries a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom LineWhile strong estimate revisions for La-Z-Boy have attracted decent investments and pushed the stock 34.8% higher over the past four weeks, further upside may still be left in the stock. So, you may consider adding it to your portfolio right away.

Analog Devices (ADI - Free Report) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.

The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this semiconductor maker, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- has this insight at its core.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

Consensus earnings estimates for the next quarter and full year have moved considerably higher for Analog Devices, as there has been strong agreement among the covering analysts in raising estimates.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate RevisionsFor the current quarter, the company is expected to earn $2.25 per share, which is a change of +38.0% from the year-ago reported number.

Over the last 30 days, the Zacks Consensus Estimate for Analog Devices has increased 8.93% because six estimates have moved higher compared to no negative revisions.

Current-Year Estimate RevisionsFor the full year, the company is expected to earn $9.74 per share, representing a year-over-year change of +25.0%.

The revisions trend for the current year also appears quite promising for Analog Devices, with nine estimates moving higher over the past month compared to no negative revisions. The consensus estimate has also received a boost over this time frame, increasing 6.08%.

Favorable Zacks RankThe promising estimate revisions have helped Analog Devices earn a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom LineInvestors have been betting on Analog Devices because of its solid estimate revisions, as evident from the stock's 22% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.

Key Takeaways ALAB is seeing strong demand for PCIe 6, Ethernet, and fabric switches across AI infrastructure builds.
ALAB expects UA Link and custom connectivity solutions to unlock new growth in next-gen AI systems.AVGO is benefiting from booming AI networking demand and a $73B AI-related order backlog.
Astera Lab (ALAB - Free Report) and Broadcom (AVGO - Free Report) are major players in the AI infrastructure market, specifically in high-speed connectivity solutions like PCIe and CXL retimers and switches. While Astera Labs focuses on PCIe 6, CXL, and Ethernet products, Broadcom has established itself as a long-standing leader in PCIe switches and infrastructure software.

Per the Mordor Intelligence report, the AI Infrastructure Market is estimated to be worth $87.60 billion in 2025. It is expected to grow to $197.64 billion by 2030, at a CAGR of 17.71% during the forecast period from 2025 to 2030. Both ALAB and AVGO are expected to benefit from this rapid growth pace.

So, ALAB or AVGO — Which of these AI Infrastructure stocks has the greater upside potential? Let’s find out.

The Case for ALAB StockAstera Lab is benefiting from the broad-based demand across its product lines, including Scorpio P-Series fabric switches, Aries PCIe 6 retimers, and Taurus Ethernet smart cable modules. Aries PCIe 6 solutions contributed more than 20% of third-quarter revenues, highlighting ALAB’s leadership in the PCIe 6 retimer market.

Astera Labs is rapidly expanding its portfolio to address the growing demands of AI infrastructure and connectivity solutions. The company recently announced plans to deliver custom connectivity solutions leveraging its COSMOS architecture and new photonic chiplet capabilities to support hyperscalers building NVLink-enabled, heterogeneous AI infrastructure.

UA Link offers a significant growth opportunity for Astera Labs. UA Link combines the memory semantics of PCIe with the high speed of Ethernet, but is devoid of the software complexity and performance limitations inherent to Ethernet. ALAB expects to deliver UA Link solutions in 2026 to solve scale-up connectivity challenges for next-generation AI infrastructure. The growing proliferation of UA Link is expected to be a multibillion-dollar additional market opportunity for Astera Labs by 2029.

Astera Labs also benefits from a rich partner base that includes top companies such as Microsoft, NVIDIA, Advanced Micro Devices, Micron Technology, and Intel.

The Case for AVGO StockBroadcom is expanding its footprint in the PCIe retimers market by developing advanced solutions that enhance signal quality and extend the reach of PCIe connections in high-speed data environments. The company’s launch of PCIe Gen 6 portfolio, featuring high-port switches and retimers tested for interoperability with partners like Micron and Teledyne LeCroy, is a noteworthy development.

The company is benefiting from strong demand for its networking products and custom AI accelerators. Broadcom’s AI revenue grew 65% year over year in fiscal 2025, reaching $20 billion. This growth is driven by AI semiconductors and infrastructure software, with AI revenue expected to double year over year to $8.2 billion in the first quarter of fiscal 2026.

Broadcom’s AI networking segment also experienced strong demand, with a $10 billion order backlog for AI switches, including the 102-terabit-per-second Tomahawk 6 switch. The company has secured record orders for DSPs, optical components, and PCI Express switches, all of which contribute to its total AI-related order backlog of $73 billion in the fourth quarter of fiscal 2026.  This backlog represents nearly half of Broadcom’s consolidated backlog of $162 billion.

Broadcom’s innovative products are also playing a crucial role in its expansion. In November, the company announced the availability of the Brocade X8 Directors and Brocade G820 56-port switch, the industry’s first 128G Fibre Channel platforms designed for mission-critical workloads and enterprise AI applications.

Price Performance and Valuation of ALAB and AVGOIn the trailing six-month period, ALAB and AVGO’s shares have gained 54.6% and 36.2%, respectively. The outperformance of ALAB stock can be attributed to its robust and diversified product portfolio, as well as its expanding partner base.

Despite AVGO’s strong portfolio, along with an expanding partner base, the company is suffering from a slight decline in gross margin due to a higher AI revenue mix and semiconductor product costs.

ALAB and AVGO Stock Performance
Image Source: Zacks Investment Research

Valuation-wise, ALAB and Broadcom shares are currently overvalued as suggested by a Value Score of F and D, respectively.

In terms of forward 12-month Price/Sales, ALAB shares are trading at 21.11X, higher than Broadcom’s 18.02X.

ALAB and AVGO Valuation
Image Source: Zacks Investment Research

How Do Earnings Estimates Compare for ALAB & AVGO?The Zacks Consensus Estimate for ALAB’s 2025 earnings is currently pegged at $1.78 per share, which has remained unchanged over the past 30 days, indicating a 111.90% year-over-year rise.

The Zacks Consensus Estimate for Broadcom’s 2025 earnings is currently pegged at $9.20 per share, which has increased 1.54% over the past 30 days, indicating a 34.90% year-over-year rise.

ConclusionWhile both ALAB and AVGO are well-positioned to capitalize on the booming AI infrastructure market, AVGO offers higher growth potential due to its massive AI backlog, diversified revenue streams, and stronger earnings.

Astera Labs’ strong fundamentals, expanding partnerships, and rising AI demand reinforce its leadership in connectivity solutions. However, challenging macroeconomic uncertainties and stiff competition remain a headwind.

Currently, Broadcom carries a Zacks Rank #2 (Buy), making the stock a stronger pick than Astera Lab, which has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

, /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Katapult Holdings, Inc. (NASDAQ: KPLT) related to its merger with The Aaron's Company, Inc. and CCF Holdings LLC. Is it a fair deal?

Click here for more info https://monteverdelaw.com/case/katapult-holdings-inc/. It is free and there is no cost or obligation to you.

NOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a lawyer and ask:

Do you file class actions and go to Court?
When was the last time you recovered money for shareholders?
What cases did you recover money in and how much?

About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

No one is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE Monteverde & Associates PC

Highlights: Anson and POSCO have made strong technical and commercial progress on cooperation at the Green River DLE Demonstration Plant, with workstreams advancing positively across all review areas. Cooperation between the parties has strengthened through detailed engineering assessments and senior-level engagement, supporting POSCO's ongoing evaluation of the project.

SAN DIEGO, CALIFORNIA - DECEMBER 6: A Southwest Airlines Boeing 737 airplane departs from San Diego International Airport en route to Phoenix on December 6, 2025 in San Diego, California. (Photo by Kevin Carter/Getty Images)

Getty Images

Southwest Airlines (LUV) stock has reached day 10 in a consecutive streak of gains, resulting in a total increase of 20% over this timeframe. The company has added approximately $2.8 billion in value during the past 10 days, bringing its current market capitalization to around $22 billion. The stock is now 24.1% higher than its value at the conclusion of 2024. This is in contrast to year-to-date returns of 15.9% for the S&P 500.

Southwest Airlines' recent success demonstrates renewed confidence from analysts, which is characterized by several price target increases and an "Overweight" rating from Morgan Stanley. Investors are also excited about growth strategies, including the introduction of the new Austin crew base and the Condor transatlantic partnership, combined with expected revenue boosts from the launch of new assigned seating soon.

What is the takeaway? Momentum frequently comes before confidence. A series of successive wins can indicate strengthening investor enthusiasm or trigger further buying. Monitoring such patterns can enable you to benefit from the upward trend or position yourself for a well-timed entry should momentum wane. Our perspective: There are various concerns regarding LUV stock due to its overall Weak operational performance and financial status. Furthermore, considering its High valuation, we believe that the stock is Unattractive (see Buy or Sell LUV).

To provide some background, LUV offers scheduled passenger air transportation services throughout the U.S. and neighboring international markets, operating a fleet of 728 Boeing 737 aircraft that serve 121 destinations.

Comparing LUV Stock Returns With The S&P 500The table below outlines the performance of LUV stock in comparison to the S&P 500 index over various periods, including the current streak:

Comparing LUV Stock Returns With The S&P 500

Trefis

However, significant gains can often come after sharp declines – but how has LUV performed following previous drops? Refer to LUV Dip Buyer Analysis for further insights.

Gains and Losses Streaks: S&P 500 ConstituentsCurrently, there are 105 S&P constituents that have experienced 3 or more days of consecutive gains and 41 constituents with 3 or more days of consecutive losses.

Gains and Losses Streaks: S&P 500 Constituents

Trefis

Key Financials for Southwest Airlines (LUV)Key Financials for Southwest Airlines (LUV)

Trefis

Although LUV stock appears attractive due to its winning streak, investing in a single stock without comprehensive analysis can be perilous. The Trefis High Quality (HQ) Portfolio, encompassing a selection of 30 stocks, boasts a history of consistently outperforming its benchmark, which includes all three — the S&P 500, S&P mid-cap, and Russell 2000 indices. What is the reason? Collectively, HQ Portfolio stocks have delivered superior returns with reduced risk compared to the benchmark index; less of a roller-coaster experience, as highlighted in HQ Portfolio performance metrics.

Apple (AAPL) has faced difficulties in the past. In 2018, its stock dropped over 30% in less than 2 months, erasing billions in market capitalization, and negating substantial gains in a single downturn. If past performance is any indication, AAPL stock is not shielded from abrupt, significant declines.

CUPERTINO, CALIFORNIA - SEPTEMBER 09: New Apple iPhone 17 Pros are displayed during an Apple special event at Apple headquarters on September 9, 2025 in Cupertino, California. Apple unveiled a new generation of iPhones, updated Apple Watches, and AirPods during a special event at its headquarters. (Photo by Justin Sullivan/Getty Images)

Getty Images

Recently, Apple’s stock has reached record levels, driven by strong demand for the iPhone 17 and booming Services revenue. Nevertheless, beneath this remarkable momentum, the elevated valuation is under greater examination, as ongoing uncertainties surrounding its complete AI strategy amid aggressive competition and enduring regulatory obstacles could easily turn present successes into future weaknesses.

What Could Lead To A Stock Decline?Regulatory Challenges: Worldwide antitrust actions, such as the EU’s Euro 500 million penalty and U.S. legal actions, threaten Apple’s profitable App Store framework, with a trial scheduled for February 2026 and recent decisions against its 27% external transaction fee.AI Development Speed: Apple is facing an expanding AI gap as its extensive Siri revamp is delayed until 2026, while competitors are rolling out features more rapidly. Apple Intelligence, concentrating on privacy and on-device processing, seeks to address this by 2026.Dependence on China: Apple’s heavy dependency on Chinese manufacturing (over 90% of iPhones) makes it vulnerable to geopolitical tensions and tariffs, which could shrink profit margins by as much as 9%. Plans for diversification to India aim for 25% of iPhone production by 2027.What’s The Worst That Could Occur?When assessing Apple’s risk, it is useful to consider how steep its declines have been during significant sell-offs. Throughout the Dot-Com Bubble, it fell by over 80%, and during the Global Financial Crisis, it dropped nearly 61%. Both the 2018 correction and the COVID sell-off led to falls of around 30-40%. The recent inflation crisis caused a decline of approximately 31%. Even solid corporations like Apple are subject to sharp downturns when the market shifts downward.

However, the risk is not confined to significant market crashes. Stocks can drop even during favorable market conditions—consider events like earnings releases, business updates, and changes in outlook. Refer to AAPL Dip Buyer Analyses to understand how the stock has bounced back from sharp drops in the past.

Is Risk Already Apparent In The Company’s Financials?Let’s examine the fundamentals.

Revenue Growth: 6.0% LTM and 1.8% 3-year average.Cash Generation: Approximately 23.5% free cash flow margin and 31.9% operating margin LTM.Valuation: Apple stock is priced at a P/E multiple of 38.2.Apple

Trefis

*LTM: Last Twelve Months

If you want more detailed information, read Buy or Sell AAPL Stock?.

Portfolios Prosper When Stock Choices Fall BehindIndividual selections can exhibit volatility, but maintaining your investment is crucial. A diversified portfolio supports you in remaining committed, capturing gains, and lessening losses.

The Trefis High Quality (HQ) Portfolio, which comprises 30 stocks, has consistently outperformed its benchmark that includes all three— the S&P 500, S&P mid-cap, and Russell 2000 indices. What accounts for this? Collectively, HQ Portfolio stocks delivered superior returns with lower risk compared to the benchmark index, resulting in a smoother investment experience, as demonstrated in HQ Portfolio performance metrics.

Revolutionary Veterinary AI Platform Ditches Dense Documentation in Favor of Clear, Engaging Video Walkthrough

MINNEAPOLIS, MN, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PetVivo.ai, the AI powered platform transforming how veterinary practices connect with pet parents, today announced something different: instead of another lengthy press release filled with jargon, they made a video.

"Let's be honest," said John Lai, CEO at PetVivo Holdings (OTCQX: PETV; OTCID: PETVW). "Most tech launches are too complicated and too long to read. We built something revolutionary, and we wanted to explain it in a way people would actually consume. So we made a video that walks through the entire ecosystem in minutes, not pages."

Show, Don't Tell

The newly released video explainer breaks down PetVivo.ai's complete two sided ecosystem in an engaging, visual format that anyone can understand. No jargon, just clear language explaining how the system works with a visual walkthrough showing the platform in action.

"We're solving a real problem for veterinary practices," continued Lai. "The last thing we wanted was for people to struggle understanding our solution. This video makes it crystal clear: here's what we built, here's how it works, here's why it matters."

What the Video Covers

The comprehensive explainer walks viewers through the two sided ecosystem, showing how PetVivo.ai connects pet parents who need veterinary care with veterinary practices who need clients. It explains all 10 specialized AI agents, from Behavioral Scientists to Radiologists, and demonstrates the complete user journey for both pet parents and veterinarians.

A Refreshing Approach

In an industry cluttered with buzzwords and technical complexity, PetVivo.ai's decision to lead with clarity represents a shift in how technology companies communicate.

"We're not trying to sound smart," said Lai. "We're trying to be understood. There's a difference."

The video is now live and available to anyone interested in understanding how AI is transforming veterinary client acquisition.

Watch the Full Explainer

The complete "How PetVivo.ai Works" video is available at https://youtu.be/zlvOjsSbErM and petvivo.ai.

For more information:

Video: https://youtu.be/zlvOjsSbErM
Website: https://petvivo.ai
Investor Relations: investors.petvivo.ai
Stock Symbol: OTCQX: PETV; OTCID: PETVW

About PetVivo.ai

PetVivo.ai is an AI powered platform that connects veterinary practices with engaged pet parents through a revolutionary two sided ecosystem. The system uses 10 specialized AI agents to transform how practices discover and connect with clients while providing pet parents with advanced health tracking tools. The platform offers a freemium model starting with a completely free tier.

About PetVivo Holdings, Inc.

PetVivo Holdings Inc. (OTCQX: PETV; OTCID: PETVW), in cooperation with its wholly owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI Inc., is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.

PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twelve patents and six trade secrets protect the Company's biomaterials, products, production processes and methods of use. The Company’s lead products SPRYNG® with OsteoCushion® technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP®, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale.

Company Contact

John Lai, CEO
PetVivo Holdings, Inc.
Email Contact: [email protected]
Tel (952) 405-6216

Forward-Looking commercial Statements

The foregoing information regarding PetVivo Holdings, Inc. (the “Company”) may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company’s proposed development and commercial timelines, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company’s business are described in detail in the Company’s Annual Report on Form 10-K for the year ended March 31, 2025, and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Kitco News

The Leading News Source in Precious Metals

Kitco NEWS has a diverse team of journalists reporting on the economy, stock markets, commodities, cryptocurrencies, mining and metals with accuracy and objectivity. Our goal is to help people make informed market decisions through in-depth reporting, daily market roundups, interviews with prominent industry figures, comprehensive coverage (often exclusive) of important industry events and analyses of market-affecting developments.